文献速递产科母胎医学

子痫前期:蜕膜化缺陷与膜联蛋白A2缺乏相关

Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2.
PubMed 文献 · Am J Obstet Gynecol · 2019-11-15

该研究探讨膜联蛋白A2缺乏在子宫内膜蜕膜化中的功能作用及其对滋养细胞浅侵入的潜在贡献。体外和体内模型显示,膜联蛋白A2表达下调与蜕膜化失败、胚胎侵入支持不足及胎盘形成缺陷相关,提示母体因素参与重度子痫前期发病。

要点

  • 重度子痫前期患者子宫内膜间质细胞体外蜕膜化时膜联蛋白A2基因和蛋白水平下调。
  • 抑制膜联蛋白A2导致蜕膜化失败,形态转化受损、催乳素和胰岛素样生长结合蛋白-1分泌降低。
  • 膜联蛋白A2缺失小鼠模型显示蜕膜化和胎盘形成功能缺陷,损害胎儿生长。

核心结论

  • 体外和体内结果提示,子宫内膜膜联蛋白A2表达缺陷损害子宫内膜间质细胞蜕膜化及促进胚胎植入和胎盘形成的子宫微环境。
  • 研究结果强调母体因素参与重度子痫前期发病,并建议评估膜联蛋白A2可能为评估女性患病风险提供新策略,或有助于发现改善蜕膜化的治疗干预。

研究设计与样本

  • 体外研究:从既往重度子痫前期女性(n=5)或正常产科结局女性(n=5)子宫内膜活检标本分离人子宫内膜间质细胞,评估体外蜕膜化过程中膜联蛋白A2基因和蛋白水平。
  • 体外模型:用small interference RNA抑制对照人子宫内膜间质细胞(n=15)中的膜联蛋白A2,分析形态学蜕膜化缺陷及催乳素和胰岛素样生长结合蛋白-1分泌。
  • 体内验证:使用膜联蛋白A2缺失小鼠模型确认蜕膜化和胎盘形成缺陷。

主要发现

  • 与对照个体相比,既往重度子痫前期女性人子宫内膜间质细胞体外蜕膜化时膜联蛋白A2基因和蛋白水平下调。
  • 抑制膜联蛋白A2表达导致蜕膜化失败,表现为形态转化受损,与肌动蛋白聚合改变及催乳素和胰岛素样生长结合蛋白-1分泌降低相关。
  • 体外模型显示,膜联蛋白A2抑制未能支持胚胎侵入,表现为经人子宫内膜间质细胞的滋养细胞铺展减少、细胞运动性缺乏,以及膜联蛋白A2抑制细胞条件培养基存在下滋养细胞侵入减少。
  • 膜联蛋白A2缺失小鼠显示蜕膜化和胎盘形成功能缺陷,损害胎儿生长,该特征与重度子痫前期相关。

临床怎么用

  • 作者认为评估膜联蛋白A2可能为评估女性发生重度子痫前期风险提供新策略,并可能发现改善蜕膜化的治疗干预。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Decidualization defects in the endometrium have been demonstrated at the time of delivery in women with severe preeclampsia and to linger for years, which suggests a maternal contribution to the pathogenesis of this condition. Global transcriptional profiling reveals alterations in gene expression, which includes down-regulation of Annexin A2 in severe preeclampsia patients with decidualization resistance. OBJECTIVE: We investigated the functional role of Annexin A2 deficiency during endometrial decidualization and its potential contribution to shallow trophoblast invasion during implantation and subsequent placentation using in vitro and in vivo modeling. STUDY DESIGN: Annexin A2 gene and protein levels were assessed during in vitro decidualization of human endometrial stromal cells isolated from biopsy specimens that were collected from women with previous severe preeclampsia (n=5) or normal obstetric outcomes (n=5). Next, Annexin A2 was inhibited with small interference RNA in control human endometrial stromal cells that were isolated from endometrial biopsy specimens (n=15) as an in vitro model to analyze decidualization defects at the morphologic level and the secretion of prolactin and insulin-like growth binding protein-1. Annexin A2-inhibited cells were used to evaluate motility and promotion of embryo invasion. Decidualization and placentation defects of Annexin A2 deficiency were confirmed with the use of an Annexin A2-null mouse model. RESULTS: Annexin A2 gene and protein levels were down-regulated during in vitro decidualization of human endometrial stromal cells from women with previous severe preeclampsia compared with control individuals. To assess its role in the endometrial stroma, we inhibited Annexin A2 expression and detected decidualization failure as evidenced by impaired morphologic transformation, which was associated with altered actin polymerization and low prolactin and insulin-like growth binding protein-1 secretions. Functionally, in vitro models demonstrated that Annexin A2 inhibition failed to support embryo invasion. This finding was corroborated by reduced trophoblast spreading through human endometrial stromal cells, lack of motility of these cells, and reduced trophoblast invasion in the presence of conditioned media from Annexin A2-inhibited cells. Extending our discovery to an animal model, we detected that Annexin A2-null mice have a functional deficiency in decidualization and placentation that impairs fetal growth as a feature that is associated with severe preeclampsia. CONCLUSION: Together, in vitro and in vivo results suggest that endometrial defects in Annexin A2 expression impair decidualization of endometrial stromal cells as well as the uterine microenvironment that promotes embryo implantation and placentation. Our findings highlight the maternal contribution to the pathogenesis of severe preeclampsia and suggest that evaluation of Annexin A2 may provide a novel strategy to assess a woman's risk of experiencing this disease and perhaps discover therapeutic interventions to improve decidualization.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Garrido-Gomez T, Quiñonero A, Dominguez F, et al. Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2. Am J Obstet Gynecol. 2019. PMID: 31738896. doi:10.1016/j.ajog.2019.11.1250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。